tip off
PHARMACEUTICAL BENEFITS SCHEME |

GP co-payments – deregulation of the bulk billing market.

In this second of a series of posts about Medicare, Margaret Faux  looks at how perverse financial incentives, the increased financial pressure applied to pensioners and GPs and the lack of supporting infrastructure make the Federal Government’s $7 GP co-payment proposal a high risk venture.  See her first post here. *** Margaret Faux writes: The [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

On the risks of private health cover of GP visits & the need for a “real” national conversation on health

In this post below, public policy expert John Menadue agrees with Health Minister Peter Dutton that we need a national conversation about health. He disagrees however that we are having one, saying we are instead seeing an “ill-considered and ideologically driven course” on both co-payments and the prospect of private health insurers being able to [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

#Budget2014 medical research fund is “unfair and unethical”

Prime Minister Tony Abbott declared on ABC Radio National’s Breakfast program this morning: “There are no cuts to health or education. In health, all of the money we are saving is going into the Medical Research Investment Fund and that’s going to be dedicated to finding the treatments and the cures of the future that [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

More strong verdicts on the Audit Commission’s “cruel, unfair, ignorant” proposals on health

This post compiles further reaction to health related recommendations of the National Commission of Audit, whose report to the Federal Government was released yesterday. First up is an impassioned response from Tim Woodruff, vice president of the Doctors Reform Society, on expansion of private health insurance and the proposals to impose a $15 GP co-payment [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Proposals for health budget savings

It’s fair to say that Peter Dutton has one of the more difficult jobs in Federal Parliament – particularly at the moment, with just over a month to go before the Federal Budget.  Under pressure from a Treasurer desperate to deliver Budget savings, the Health Minister will need to offer up something in his rapidly [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

TPP update: Talks stall as concern grows

Last week Dr Deb Gleeson updated us on her plans to attend the final meeting of the Trans Pacific Partnership (TPP) negotiations in order to continue raising concerns about the impact of the agreement on health in Australia and other nations.  Yesterday she tweeted the following: “URGENT NEWS FROM SINGAPORE: Australia has caved in to US [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Weighing up the Coalition’s health policy (and finding it pretty light-on)

When weighing up the various election policies through a health lens, some of the most important issues to consider are: 1. How do the policies address climate change, the major public health issue that we – as Australians, as the planet – are facing? 2. How are health inequalities addressed? Is there an explicit commitment [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

War on drugs: campaign against Pharmacy Guild PBS claims

Three major health, consumer and social sector groups have joined together in a campaign to highlight the high prices paid for prescription medicines in Australia. The Consumers Health Forum of Australia, CHOICE and the Australian Council of Social Service (ACOSS) are calling on consumers to put pressure on MPs and candidates for the coming federal [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Health sector wish-lists: a pre-Budget round-up

With less than a week to go before the Federal Budget 2013, the leaks and rumours (and rumours about leaks) are increasing and speculation about possible new funding measures is mounting. The following analysis looks at the main items on the wish-lists of eight peak health groups and identifies key issues on which there is [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

The decision to recommend PBS listing for RU486 is a significant advance in Australian women’s reproductive health care

Professor Caroline de Costa, from the James Cook University School of Medicine, and Dr Michael Carrette were the first clinicians in Australia to prescribe RU486, having pioneered the Authorised Prescriber approach. Below they provide insight into the implications of last week’s important decision to recommend PBS listing for RU486. The decision, announced last Friday by [...]

READ MORE

Womens Agenda

loading...

Smart Company

loading...

StartupSmart

loading...

Property Observer

loading...